In a significant transfer, SII had lowered the worth of its Covid-19 vaccine ‘Covishield’ from 400 to 300 per dose for states

ANI | , New Delhi

PUBLISHED ON MAY 02, 2021 07:27 AM IST

Adar Poonawalla, CEO of Serum Institute of India (SII) on Saturday night time stated that the manufacturing of Covid-19 vaccine Covishield is in full swing in Pune.

The SII CEO additionally held a gathering together with his companions and stakeholders within the UK.

“Had an excellent meeting with all our partners & stakeholders in the UK. Meanwhile, pleased to state that COVISHIELD’s production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days,” tweeted Poonawalla.

In a significant transfer, SII had lowered the worth of its Covid-19 vaccine ‘Covishield’ from 400 to 300 per dose for states on Wednesday.

The Ministry of Home Affairs (MHA) on Wednesday additionally supplied Poonawalla with Y class safety throughout the nation by the Central Reserve Police Force (CRPF).

Earlier this month, Adar Poonawalla had requested the federal government for monetary help to ramp up vaccine manufacturing.

Close


Follow us on Google News

VNAP News Portal